Literature DB >> 30771578

Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.

Lijun Peng1, Chongfeng Bi2, Deyu Xia3, Linling Mao4, Hairong Qian5.   

Abstract

BACKGROUND: Central nervous system (CNS) inflammatory demyelinating disease (IDD) is an immune-mediated disease that is pathologically characterized by demyelination and inflammatory infiltration in the CNS and includes clinically isolated syndrome (CIS), multiple sclerosis (MS), and neuromyelitis optica spectrum disorders (NMOSD). IDD is usually characterized by variable symptoms, multivariate imaging, uncertain reactions to treatment, and a variable prognosis, which makes it difficult to diagnose early. In recent years, the role of the neurofilament light chain (NFL), an axonal injury biomarker, in IDD has become increasingly important. We will detect and analyse cerebrospinal fluid (CSF) NFL levels in IDD and normal control patients to determine the significance of NFL in the diagnosis and prognostic prediction of IDD.
METHODS: A total of 41 CIS, 34 MS and 73 NMOSD patients and 40 other patients with conditions such as neurosis and migraine with lumbar puncture were enrolled as the patient groups and the normal control (NC) group from the population of in- and outpatients of the Department of Neurology of the Sixth Medical Centre of Chinese People's Liberation Army General Hospital from January 2014 to October 2016. Clinical and neuroimaging features of the patient groups as well as CSF samples from both types of groups were collected, and the NFL levels of CSF were measured by enzyme linked immunosorbent assay.
RESULTS: CSF NFL levels in the CIS, MS and NMOSD groups were significantly higher than those in the NC group (P < 0.05, analysis of variance of NFL levels was performed after logarithmic transformation based on 10). There were no statistically significant differences in the CSF NFL levels among the CIS, MS and NMOSD groups (P > 0.05). The NFL levels of CSF in the CIS, MS and NMOSD groups were correlated with the expanded disability status scale score and enhancement in gadolinium-magnetic resonance imaging (all P < 0.05). Gender, oligoclonal band in CSF, aquaporin 4 antibody and 25‑hydroxy vitamin D3 [25(OH)D3] in serum were not related to the NFL levels (P > 0.05).
CONCLUSION: The NFL level of CSF is conducive to assessing the severity and probable progress of IDD but is not helpful in distinguishing IDD among Chinese.
Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Demyelinating disease; Diagnosis; Neurofilament light chain; Prognosis

Mesh:

Substances:

Year:  2019        PMID: 30771578     DOI: 10.1016/j.msard.2019.02.009

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  5 in total

1.  Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up.

Authors:  Magdalena Bruzova; Robert Rusina; Zuzana Stejskalova; Radoslav Matej
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

2.  Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis.

Authors:  Antti Cajanus; Kasper Katisko; Aleksi Kontkanen; Olli Jääskeläinen; Päivi Hartikainen; Annakaisa Haapasalo; Sanna-Kaisa Herukka; Ritva Vanninen; Eino Solje; Anette Hall; Anne M Remes
Journal:  Ann Clin Transl Neurol       Date:  2020-05-22       Impact factor: 4.511

Review 3.  Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations.

Authors:  Tamás Biernacki; Zsófia Kokas; Dániel Sandi; Judit Füvesi; Zsanett Fricska-Nagy; Péter Faragó; Tamás Zsigmond Kincses; Péter Klivényi; Krisztina Bencsik; László Vécsei
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

4.  A Longitudinal, Observational Analysis of Neuronal Injury Biomarkers in a Case Report of a Patient With Paraneoplastic Anti-CRMP5 Antibody-Associated Transverse Myelitis.

Authors:  Christopher Mizenko; Jeffrey L Bennett; Gregory Owens; Timothy L Vollmer; Amanda L Piquet
Journal:  Front Neurol       Date:  2021-07-16       Impact factor: 4.003

Review 5.  The potential of serum neurofilament as biomarker for multiple sclerosis.

Authors:  Stefan Bittner; Jiwon Oh; Eva Kubala Havrdová; Mar Tintoré; Frauke Zipp
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.